{"id":107505,"date":"2026-05-14T22:29:09","date_gmt":"2026-05-14T22:29:09","guid":{"rendered":"https:\/\/www.europesays.com\/be-fr\/107505\/"},"modified":"2026-05-14T22:29:09","modified_gmt":"2026-05-14T22:29:09","slug":"thromboses-veineuses-aigues-profondes-apixaban-ou-rivaroxaban-le-quotidien-du-medecin","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/be-fr\/107505\/","title":{"rendered":"Thromboses veineuses aigu\u00ebs profondes\u00a0: apixaban ou rivaroxaban\u00a0? | Le Quotidien du M\u00e9decin"},"content":{"rendered":"<p class=\"component:body\">Risque h\u00e9morragique de l\u2019apixaban versus le rivaroxaban dans le traitement des thromboses veineuses aigu\u00ebs profondes<br \/>Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism<br \/>Castellucci LA, Chen WN, Kovacs MJ et al for the COBRRA (Comparison of Bleeding Risk between Rivaroxaban and Apixaban) Trial Investigators.<br \/>New Engl J Med 2026;394:1051-60.<br \/><a href=\"https:\/\/doi.org\/10.1056\/NEJMoa2510703\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/doi.org\/10.1056\/NEJMoa2510703<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Risque h\u00e9morragique de l\u2019apixaban versus le rivaroxaban dans le traitement des thromboses veineuses aigu\u00ebs profondesBleeding Risk with Apixaban&hellip;\n","protected":false},"author":2,"featured_media":107506,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[82],"tags":[12,13,18,17,86,87],"class_list":{"0":"post-107505","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-be","9":"tag-be-fr","10":"tag-belgique","11":"tag-belgium","12":"tag-health","13":"tag-sante"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@be_fr\/116575296731965307","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/107505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/comments?post=107505"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/107505\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media\/107506"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media?parent=107505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/categories?post=107505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/tags?post=107505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}